Serum Metabolites as Diagnostic Biomarkers in Patients with Endometriosis
- PMID: 38649667
- DOI: 10.1007/s43032-024-01536-5
Serum Metabolites as Diagnostic Biomarkers in Patients with Endometriosis
Abstract
Endometriosis diagnosis is usually delayed. The gold standard for diagnosing endometriosis is laparoscopy, which is invasive and accompanied by several risks. Currently, there are no effective non-invasive biomarkers for diagnosing endometriosis. Here, we investigated whether metabolites whose levels are altered in patients with endometriosis hold potential as diagnostic biomarkers for the disease. This case-control study involved 32 patients with endometriosis and 29 patients with other benign gynecological disease. The diagnosis of all patients was confirmed through postoperative histopathological examination, and the patients were divided into two groups: an endometriosis group (EM) and a control group. Fasting blood was collected and used for non-targeted metabolomic-based detection. The data were processed through principal component analysis, orthogonal partial least squares discriminant analysis, and significance analysis of microarrays. A univariate receiver operating characteristic curve was used to evaluate the diagnostic value of the metabolites. The metabolite profiles of patients with endometriosis were markedly different compared with those of the controls. In addition, several metabolic pathways, including biosynthesis of unsaturated fatty acids, arginine biosynthesis, and glutathione metabolism, were altered. Ornithine and medorinone showed better potential as biomarkers for endometriosis diagnosis than CA125. We analyzed the altered metabolic profiles in patients with endometriosis and found ornithine and medorinone as potential non-invasive biomarkers for endometriosis diagnosis, whereas the combined ornithine-medorinone diagnosis is more valuable. These findings may help advance research on non-invasive diagnostic biomarkers for endometriosis. Further research with an improved study design and a larger cohort should be performed to confirm the diagnostic potential and clinical application of these biomarkers.
Keywords: Biomarker; Diagnosis; Endometriosis; Metabolite.
© 2024. The Author(s), under exclusive licence to Society for Reproductive Investigation.
Conflict of interest statement
Declarations. Conflicts of interest: The authors report no conflict of interest. Research involving human participants ethics approval: This study was approved by the Ethics Committee of Medical Integration and Practice Center at the Cheeloo College of Medicine, Shandong University [SDULCLL2022-1–21]. The procedures used in this study adhere to the tenets of the Declaration of Helsinki. Informed consent: Informed consent was obtained from the patients before surgery. Consent to publish: Not applicable.
Similar articles
-
Metabolic Profile of Patients with Severe Endometriosis: a Prospective Experimental Study.Reprod Sci. 2021 Mar;28(3):728-735. doi: 10.1007/s43032-020-00370-9. Epub 2020 Nov 10. Reprod Sci. 2021. PMID: 33174185 Free PMC article.
-
Endometrium metabolomic profiling reveals potential biomarkers for diagnosis of endometriosis at minimal-mild stages.Reprod Biol Endocrinol. 2018 Apr 30;16(1):42. doi: 10.1186/s12958-018-0360-z. Reprod Biol Endocrinol. 2018. PMID: 29712562 Free PMC article.
-
TGFBI as a candidate biomarker for non-invasive diagnosis of early-stage endometriosis.Hum Reprod. 2023 Jul 5;38(7):1284-1296. doi: 10.1093/humrep/dead091. Hum Reprod. 2023. PMID: 37187159 Free PMC article.
-
Is there a role for small molecule metabolite biomarkers in the development of a diagnostic test for endometriosis?Syst Biol Reprod Med. 2022 Apr;68(2):89-112. doi: 10.1080/19396368.2022.2027045. Epub 2022 Mar 31. Syst Biol Reprod Med. 2022. PMID: 35361022 Review.
-
Metabolomics in endometriosis: challenges and perspectives for future studies.Reprod Fertil. 2021 May 6;2(2):R35-R50. doi: 10.1530/RAF-20-0047. eCollection 2021 Apr. Reprod Fertil. 2021. PMID: 35128453 Free PMC article. Review.
References
-
- Zondervan KT, Becker CM, Missmer SA. Endometriosis. New England J Med. 2020;382(13):1244–56. https://doi.org/10.1056/NEJMra1810764 . - DOI
-
- França PRDC, Lontra ACP, Fernandes PD. Endometriosis: a disease with few direct treatment options. Molecules (Basel, Switzerland). 2022;27(13). https://doi.org/10.3390/molecules27134034
-
- Nnoaham KE, Hummelshoj L, Webster P, et al. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril. 2011;96(2). https://doi.org/10.1016/j.fertnstert.2011.05.090
-
- Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet (London, England). 2021;397(10276):839–52. https://doi.org/10.1016/S0140-6736(21)00389-5 . - DOI - PubMed
-
- Nisenblat V, Bossuyt PMM, Farquhar C, et al. Imaging modalities for the non-invasive diagnosis of endometriosis. Cochrane Database System Rev. 2016;2(2):CD009591. https://doi.org/10.1002/14651858.CD009591.pub2 . - DOI
MeSH terms
Substances
Grants and funding
- 2022YFC2704000/the National Key R&D Program of China
- 82301855/the National Natural Science Foundation of China
- ZR2021ZD34/the Major Basic Research of Natural Science Foundation of Shandong
- 82071621/National Natural Science Foundation of China
- ZR2023QH186/Natural Science Foundation of Shandong Province
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous